Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Carleton

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 26, 2021
Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapyCatrina M Loucks, Kevin Yan, Reo Tanoshima, et al.
Frontiers in Pharmacology|September 25, 2023
Implementation of pharmacogenetic testing in oncology: <i>DPYD</i>-guided dosing to prevent fluoropyrimidine toxicity in British ColumbiaAngela Wu, Helen Anderson, Curtis Hughesman, et al.
Journal of Clinical Psychopharmacology|June 15, 2018
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological StudyMichael Y Guo, Mahyar Etminan, Ric M Procyshyn, et al.
Plos One|April 14, 2017
Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell linesAmit P Bhavsar, Erandika P Gunaretnam, Yuling Li, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 15, 2016
Asthma in British Columbia: Are we finally breathing easier? A population-based study of the burden of disease over 14 yearsStan Bardal, Anne Smith, Hao Allan Luo, et al.
Therapeutic Drug Monitoring|June 21, 2013
Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothersJessica Lam, Lauren Kelly, Ilan Matok, et al.
Pharmacogenomics|September 24, 2010
Pharmacogenomics and active surveillance for serious adverse drug reactions in childrenTenneille T Loo, Colin J D Ross, Johanna Sistonen, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|November 12, 2013
Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapyParvaz Madadi, Ursula Amstutz, Michael Rieder, et al.
Forensic Science International|April 22, 2014
Codeine-related deaths: The role of pharmacogenetics and drug interactionsJessica Lam, Karen L Woodall, Patricia Solbeck, et al.
Epilepsia|March 7, 2014
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactionsUrsula Amstutz, Neil H Shear, Michael J Rieder, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Basic & Clinical Pharmacology & Toxicology|April 26, 2021
Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapyCatrina M Loucks, Kevin Yan, Reo Tanoshima, et al.
Frontiers in Pharmacology|September 25, 2023
Implementation of pharmacogenetic testing in oncology: <i>DPYD</i>-guided dosing to prevent fluoropyrimidine toxicity in British ColumbiaAngela Wu, Helen Anderson, Curtis Hughesman, et al.
Journal of Clinical Psychopharmacology|June 15, 2018
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological StudyMichael Y Guo, Mahyar Etminan, Ric M Procyshyn, et al.
Plos One|April 14, 2017
Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell linesAmit P Bhavsar, Erandika P Gunaretnam, Yuling Li, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 15, 2016
Asthma in British Columbia: Are we finally breathing easier? A population-based study of the burden of disease over 14 yearsStan Bardal, Anne Smith, Hao Allan Luo, et al.
Therapeutic Drug Monitoring|June 21, 2013
Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothersJessica Lam, Lauren Kelly, Ilan Matok, et al.
Pharmacogenomics|September 24, 2010
Pharmacogenomics and active surveillance for serious adverse drug reactions in childrenTenneille T Loo, Colin J D Ross, Johanna Sistonen, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|November 12, 2013
Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapyParvaz Madadi, Ursula Amstutz, Michael Rieder, et al.
Forensic Science International|April 22, 2014
Codeine-related deaths: The role of pharmacogenetics and drug interactionsJessica Lam, Karen L Woodall, Patricia Solbeck, et al.
Epilepsia|March 7, 2014
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactionsUrsula Amstutz, Neil H Shear, Michael J Rieder, et al.
Pageof 14